News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
An international group of researchers aim to develop an approach that may be able to diagnose multiple conditions, including pneumonia, tuberculosis, sepsis, with one blood sample.
The clinical study will evaluate a next-generation sequencing-based test, which has the potential to detect all known respiratory pathogens in 12 hours.
Among the study's goals is to identify molecular signatures that can distinguish idiopathic pulmonary fibrosis from interstitial lung disease.
A CFTR gene mutation found in 90 percent of US cystic fibrosis patients was only present in a third of Puerto Rican and 10 percent of Dominican patients.
A new partnership and licensing agreement will help the research institute aggregate genotype and phenotype data for the NIH-funded PreCISE Network asthma program.
